2023-01-25 01:20:00

GATC Health to Speak at the Opioid Settlement Abatement Summit in Washington DC

Logo Benzinga
By Pr Newswire

GATC to highlight its AI-driven addiction solutions to a national audience attending to learn how to allocate the tens of billions of dollars resulting from opioid abatement settlements for states, counties, municipalities and tribes; Dr. Rahul Gupta, director of the Office of National Drug Control Policy,will be the keynote speakers

IRVINE, Calif., Jan. 24, 2023 /PRNewswire/ -- GATC Health Corp, a science and technology company revolutionizing drug discovery and disease prediction using artificial intelligence (AI), today announced that Tyrone Lam, COO of GATC Health, will present the company's fentanyl abatement drug candidates that were identified by GATC's AI-based drug discovery and development platform. The novel created by GATC are currently in preclinical drug evaluation studies. Guidelines allocated a portion of the Opioid Abatement Settlement funds for research and development, which includes GATC's opioid addiction abatement projects.

GATC will present AI-driven addiction solutions to a national audience of states, counties, municipalities and tribes

The allocation of opioid settlement funds to states has already begun, yet many states are lagging in their efforts to organize an adequate abatement plan or council to direct and oversee the distribution. The Opioid Settlement Abatement SummitModel Guidance for States, Counties, Municipalities and Tribes will take place on Thursday January 26th, 2023at Georgetown University and virtually, and focus on providing model abatement guidance for states, counties, municipalities and tribes to effectively plan for, implement and track opioid settlement funds.The goal of the event is to highlight effective programs, initiatives and tools that are easily adopted and should be considered in state abatement plans as funding begins to come in.

Continue read on benzinga.com

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 23:15:00
New report addresses what to expect for AI, FWA, payment integrity, cloud data security and more over the next 12 months ATLANTA, Jan. 24, 2023...

Logo PR Newswire
TechnologyPress Release2023-01-24 13:00:00
Expanded partnership to deliver high-quality, affordable care to members wherever they are TROY, N.Y., Jan. 24, 2023 /PRNewswire/ -- UCM Digital Health...

Logo PR Newswire
HealthPress Release2023-01-24 17:40:00
SILVER SPRING, Md., Jan. 24, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the...

Logo PR Newswire
HealthPress Release2023-01-24 13:07:00
The study will evaluate repeat low doses of psilocybin for safety, tolerability, and efficacy in treating generalized anxiety disorder (GAD) on a take-home...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:21:00
Company cofounder to discuss use of artificial intelligence and machine learning applications for precision medicine in neurology BOSTON, Jan. 24, 2023...

Logo Bloomberg
PoliticsBy Riley Griffin2023-01-24 18:39:14
US public health chief Rochelle Walensky continued reconfiguring her agency to fight crises after stinging criticism of its pandemic response, hiring new...

Logo PR Newswire
TechnologyPress Release2023-01-24 15:00:00
Collaboration supports shift to Value-Based Care and focus on innovative solutions to advance accessible, affordable, quality care ANNAPOLIS, Md., Jan. 24,...

Logo NewsFileCorp
Press Release2023-01-24 12:30:00
Study Has Potential to Lead to In-Licensing Agreement and Accelerated Pathway to Phase II Toronto, Ontario--(Newsfile Corp. - January 24, 2023) - Awakn Life...

Logo GlobeNewswire
EconomyPress Release2023-01-24 14:45:00
Artificial Intelligence in Healthcare Market Trends and Insights By Component (Hardware, Software, Services), Application (Robot-Assisted Surgery, Virtual...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 17:09:00
Competing teams were challenged to develop and demonstrate effective rapid training and reskilling solutions for individuals most vulnerable to employment...

Logo GlobeNewswire
NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 21:52:00
Open Source Diabetes Nonprofit Brings Community-Led Innovation in the Form of the First iPhone-Controlled Interoperable Automated Glycemic Controller for...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-25 00:16:00
Commissioner's Office and NICB Personnel Deployed to Catastrophe Claims Village DES PLAINES, Ill., Jan. 24, 2023 /PRNewswire/ -- Deadly tornados moved across...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 15:45:00
Access to quality data through the Standard is critical for pharmacists to provide clinical care, fortify patient safety and accelerate access to specialty...

Logo Global News
HealthBy Teresa Wright2023-01-24 11:00:47
As political pressure builds on the federal Liberals pledge to usher in Canadas first ever national drug coverage program, questions are being raised about...

Logo PR Newswire
HealthPress Release2023-01-24 14:00:00
OTTAWA, ON, Jan. 24, 2023 /CNW/ - The Public Policy Forum released an important new report today entitled Taking Back Health Care: How to Accelerate...

Logo GlobeNewswire
SciencePress Release2023-01-24 21:15:00
LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti or the Company) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma...

Logo GlobeNewswire
HealthPress Release2023-01-24 14:00:00
Long-standing, Employee-driven Support of Philanthropic Efforts Grows 20% Year-Over-Year BOWIE, Md., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Inovalon, a leading...

Logo EIN Presswire
HealthPress Release2023-01-24 13:24:22
Emergen Research Logo Increasing government support and initiatives is a significant factor driving global medical device connectivity market revenue growth...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS)...